Ironwood Pharmaceuticals, Inc. (IRWD) Stock Analysis

Free AI-powered analysis and research for Ironwood Pharmaceuticals, Inc. stock

Sector: Healthcare

Analyze Ironwood Pharmaceuticals, Inc. (IRWD) Stock

Ironwood Pharmaceuticals, Inc. (IRWD) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into IRWD stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Ironwood Pharmaceuticals, Inc. stock.

Analyze IRWD Now →

📰 Latest Update

Ironwood (IRWD) Q2 2026 Earnings Call Transcript

Thu, August 13, 2026 at 5:43 PM UTC 3 min read

Ironwood Pharmaceuticals (IRWD) reported its Q2 2026 earnings, highlighting a significant increase in revenue driven by strong sales of its flagship product, Linzess. The company also announced progress in its pipeline, with promising data from ongoing clinical trials. This positive performance and potential for future growth are encouraging for investors, suggesting a solid trajectory for the company's financial health and market position.

Read full article →